LIVE NEWS
  • Dutch far-right party pays damages to court artist after changing image with AI | Netherlands
  • Smarter Summer Vacations: The Best AI Travel Gadgets to Pack This Year
  • European, island states seek clear future for global roadmap to cut fossil fuels
  • Trump privacy restrictions may reduce Census Bureau data : NPR
  • Can fasting fight gum disease? Scientists find surprising link
  • 5 Raspberry Pi projects I’m self-hosting this year instead of wasting money on monthly subscriptions
  • Women’s T20 World Cup: Danni Wyatt-Hodge on scoring ‘mummy’ hundred
  • Google unveils DiffusionGemma, an AI model that breaks free of left-to-right processing
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • See More
    • Artificial Intelligence
    • Climate Risks
    • Defense
    • Healthcare Innovation
    • Science
    • Technology
    • World
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • Artificial Intelligence
  • Climate Risks
  • Defense
  • Healthcare Innovation
  • Science
  • Technology
  • World
Home»Healthcare Innovation»GOP Sen. Johnson investigating FDA rare disease drug rejections
Healthcare Innovation

GOP Sen. Johnson investigating FDA rare disease drug rejections

primereportsBy primereportsMarch 11, 2026No Comments1 Min Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
GOP Sen. Johnson investigating FDA rare disease drug rejections
Share
Facebook Twitter LinkedIn Pinterest Email


WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease treatments.

The Wisconsin Republican is requesting denial letters, called complete response letters, that the FDA sent to makers of rare disease treatments for conditions including ataxia and Sanfilippo syndrome. He said he’s heard that some of the issues in those letters are “nitpicky things.” 

“We’re going to find out exactly what issues the FDA listed for their ‘nos’,” he said.

STAT+ Exclusive Story

Already have an account? Log in

GOP Sen. Johnson investigating FDA rare disease drug rejections



STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWhat to Do in Chicago If You’re Here for Business (2026)
Next Article ICE says Camp East Montana detention facility staying open, not closing
primereports
  • Website

Related Posts

Healthcare Innovation

Can fasting fight gum disease? Scientists find surprising link

June 13, 2026
Healthcare Innovation

New proposal would close Medicare drug price negotiation loophole

June 13, 2026
Healthcare Innovation

Scientists found the strength training sweet spot for a longer life

June 12, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Paxton’s win over Cornyn sets up high-stakes Texas clash with Talarico

May 28, 202616 Views

Global Resources Outlook 2024 | UNEP

December 6, 202510 Views

Texas Democrat Talarico claims voting laws are rigged ahead of Paxton race

May 28, 20269 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest Reviews

Subscribe to Updates

Get the latest tech news from FooBar about tech, design and biz.

PrimeReports.org
Independent global news, analysis & insights.

PrimeReports.org brings you in-depth coverage of geopolitics, markets, technology and risk – with context that helps you understand what really matters.

Editorially independent · Opinions are those of the authors and not investment advice.
Facebook X (Twitter) LinkedIn YouTube
Key Sections
  • World
  • Geopolitics
  • Popular Now
  • Artificial Intelligence
  • Cybersecurity
  • Crypto
All Categories
  • Artificial Intelligence
  • Climate Risks
  • Crypto
  • Cybersecurity
  • Defense
  • Economy
  • Geopolitics
  • Global Markets
  • Healthcare Innovation
  • Politics
  • Popular Now
  • Science
  • Technology
  • World
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • DMCA / Copyright Notice
  • Editorial Policy

Sign up for Prime Reports Briefing – essential stories and analysis in your inbox.

By subscribing you agree to our Privacy Policy. You can opt out anytime.
Latest Stories
  • Dutch far-right party pays damages to court artist after changing image with AI | Netherlands
  • Smarter Summer Vacations: The Best AI Travel Gadgets to Pack This Year
  • European, island states seek clear future for global roadmap to cut fossil fuels
© 2026 PrimeReports.org. All rights reserved.
Privacy Terms Contact

Type above and press Enter to search. Press Esc to cancel.